Divit Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 Cr
as on 17-11-2024
- Revenue -0.34%
(FY 2023)
- Profit -96.23%
(FY 2023)
- Ebitda -60.00%
(FY 2023)
- Net Worth 0.55%
(FY 2023)
- Total Assets 41.69%
(FY 2023)
About Divit Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.70 Cr.
Vikrant Tomar, Prashant Tomar, and Ompal Tomar serve as directors at the Company.
- CIN/LLPIN
U51900UP2013PTC121147
- Company No.
121147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Divit Nutraceuticals Private Limited offer?
Divit Nutraceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Multivitamin Syrup & Drops, Protein Powder, Nutraceuticals, Dietary Supplements, Multivitamin Tablets & Capsules, Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Common Disease Medicines.
Who are the key members and board of directors at Divit Nutraceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikrant Tomar  | Director | 15-Mar-2013 | Current |
| Prashant Tomar | Director | 15-Mar-2013 | Current |
| Ompal Tomar | Director | 22-Nov-2014 | Current |
Financial Performance of Divit Nutraceuticals.
Divit Nutraceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.34% decrease. The company also saw a substantial fall in profitability, with a 96.23% decrease in profit. The company's net worth moved up by a moderate rise of 0.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Divit Nutraceuticals?
In 2023, Divit Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Triend Software Private LimitedActive 9 years 7 monthsVikrant Tomar and Ompal Tomar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Feb 2024 | ₹1.40 Cr | Open |
Others Creation Date: 18 May 2022 | ₹1.15 Cr | Open |
Others Creation Date: 08 Mar 2018 | ₹1.50 M | Open |
How Many Employees Work at Divit Nutraceuticals?
Unlock and access historical data on people associated with Divit Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Divit Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divit Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
